Mycenax Biotech Inc. (TPEX:4726)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.60
-0.45 (-1.36%)
Mar 10, 2026, 9:34 AM CST

Mycenax Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
6,8488,9677,3507,6995,8114,129
Upgrade
Market Cap Growth
-25.85%22.00%-4.53%32.48%40.74%38.50%
Upgrade
Enterprise Value
7,7519,4817,2818,3535,9983,966
Upgrade
Last Close Price
33.0543.4035.7037.5037.9032.20
Upgrade
PE Ratio
-----133.43
Upgrade
PS Ratio
10.5413.1111.2610.517.516.21
Upgrade
PB Ratio
4.174.433.002.483.053.41
Upgrade
P/TBV Ratio
4.264.513.062.523.143.59
Upgrade
P/OCF Ratio
-----23.71
Upgrade
EV/Sales Ratio
11.9313.8611.1611.417.755.96
Upgrade
EV/EBITDA Ratio
----135.3226.30
Upgrade
EV/EBIT Ratio
-----112.05
Upgrade
Debt / Equity Ratio
0.680.440.300.310.390.16
Upgrade
Debt / EBITDA Ratio
----9.961.15
Upgrade
Net Debt / Equity Ratio
0.550.300.02-0.120.24-0.08
Upgrade
Net Debt / EBITDA Ratio
-4.43-2.93-0.171.7510.33-0.63
Upgrade
Net Debt / FCF Ratio
-3.08-1.16-0.140.49-0.371.10
Upgrade
Asset Turnover
0.190.190.160.190.320.42
Upgrade
Inventory Turnover
9.9810.445.734.034.936.79
Upgrade
Quick Ratio
0.380.640.972.241.151.10
Upgrade
Current Ratio
0.751.111.463.031.661.36
Upgrade
Return on Equity (ROE)
-25.64%-20.90%-24.59%-18.10%-5.76%2.67%
Upgrade
Return on Assets (ROA)
-8.14%-8.08%-9.15%-7.33%-2.18%1.40%
Upgrade
Return on Capital Employed (ROCE)
-19.70%-17.10%-20.00%-11.70%-3.30%2.70%
Upgrade
Earnings Yield
-7.00%-5.21%-9.29%-5.89%-1.55%0.75%
Upgrade
FCF Yield
-4.28%-5.82%-5.81%-10.09%-21.41%-2.08%
Upgrade
Buyback Yield / Dilution
-0.52%-0.23%-24.31%-11.35%-15.36%-2.37%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.